Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD 54.30
+0.10 (0.18%)
Jan 21, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 7.01 billion as of January 21, 2025. Its market cap has decreased by -32.73% in one year.
Market Cap
7.01B
Enterprise Value
5.52B
Revenue
50.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.30
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 7.01B, an increase of 44.28%. That is a compound annual growth rate of 13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 7.01B | 2.65% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 230.69B |
| Caliway Biopharmaceuticals | 103.57B |
| Bora Pharmaceuticals Co., LTD. | 84.53B |
| Lotus Pharmaceutical | 68.47B |
| Lumosa Therapeutics | 39.94B |
| Oneness Biotech | 37.72B |
| Polaris Group | 32.91B |
| Center Laboratories | 29.21B |